BioPorto Statistics

Total Valuation

BioPorto has a market cap or net worth of DKK 561.44 million. The enterprise value is 542.18 million.

Market Cap	561.44M
Enterprise Value	542.18M

Important Dates

The last earnings date was Wednesday, November 19, 2025.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	n/a

Share Statistics

BioPorto has 495.10 million shares outstanding. The number of shares has increased by 12.04% in one year.

Current Share Class	495.10M
Shares Outstanding	495.10M
Shares Change (YoY)	+12.04%
Shares Change (QoQ)	+1.47%
Owned by Insiders (%)	0.43%
Owned by Institutions (%)	0.29%
Float	492.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.36
PB Ratio	15.96
P/TBV Ratio	16.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.25
EV / Sales	14.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.66

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.24.

Current Ratio	1.91
Quick Ratio	1.63
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-57.52

Financial Efficiency

Return on equity (ROE) is -142.61% and return on invested capital (ROIC) is -81.09%.

Return on Equity (ROE)	-142.61%
Return on Assets (ROA)	-61.71%
Return on Invested Capital (ROIC)	-81.09%
Return on Capital Employed (ROCE)	-217.77%
Revenue Per Employee	761,688
Profits Per Employee	-1.81M
Employee Count	48
Asset Turnover	0.41
Inventory Turnover	2.55

Taxes

Income Tax	-6.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.83% in the last 52 weeks. The beta is 1.31, so BioPorto's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-34.83%
50-Day Moving Average	1.20
200-Day Moving Average	1.35
Relative Strength Index (RSI)	49.40
Average Volume (20 Days)	388,066

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioPorto had revenue of DKK 36.56 million and -86.80 million in losses. Loss per share was -0.20.

Revenue	36.56M
Gross Profit	23.36M
Operating Income	-87.38M
Pretax Income	-93.34M
Net Income	-86.80M
EBITDA	-86.54M
EBIT	-87.38M
Loss Per Share	-0.20

Full Income Statement

Balance Sheet

The company has 27.59 million in cash and 8.34 million in debt, giving a net cash position of 19.26 million or 0.04 per share.

Cash & Cash Equivalents	27.59M
Total Debt	8.34M
Net Cash	19.26M
Net Cash Per Share	0.04
Equity (Book Value)	35.18M
Book Value Per Share	0.08
Working Capital	25.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -79.64 million and capital expenditures -1.72 million, giving a free cash flow of -81.36 million.

Operating Cash Flow	-79.64M
Capital Expenditures	-1.72M
Free Cash Flow	-81.36M
FCF Per Share	-0.16

Full Cash Flow Statement

Margins

Gross margin is 63.90%, with operating and profit margins of -238.98% and -237.40%.

Gross Margin	63.90%
Operating Margin	-238.98%
Pretax Margin	-255.29%
Profit Margin	-237.40%
EBITDA Margin	-236.70%
EBIT Margin	-238.98%
FCF Margin	n/a

Dividends & Yields

BioPorto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.04%
Shareholder Yield	-12.04%
Earnings Yield	-15.46%
FCF Yield	-14.49%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioPorto has an Altman Z-Score of 0.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	2